Blume Capital Management’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-400
Closed -$9.49K 321
2024
Q1
$9.49K Sell
400
-400
-50% -$8.89K ﹤0.01% 251
2023
Q4
$19.2K Hold
800
0.01% 220
2023
Q3
$17.5K Sell
800
-800
-50% -$16.7K 0.01% 219
2023
Q2
$30.6K Hold
1,600
0.01% 195
2023
Q1
$31.1K Hold
1,600
0.01% 188
2022
Q4
$25.7K Hold
1,600
0.01% 197
2022
Q3
$25K Hold
1,600
0.01% 190
2022
Q2
$33K Sell
1,600
-512
-24% -$10.6K 0.01% 179
2022
Q1
$48K Hold
2,112
0.02% 159
2021
Q4
$39K Hold
2,112
0.01% 184
2021
Q3
$45K Hold
2,112
0.02% 178
2021
Q2
$38K Sell
2,112
-1,600
-43% -$37.3K 0.01% 184
2021
Q1
$84K Hold
3,712
0.03% 124
2020
Q4
$75K Buy
3,712
+512
+16% +$10.7K 0.03% 106
2020
Q3
$78K Hold
3,200
0.04% 99
2020
Q2
$76K Sell
3,200
-2,000
-38% -$46.4K 0.04% 97
2020
Q1
$89K Sell
5,200
-1,000
-16% -$18.3K 0.06% 85
2019
Q4
$109K Hold
6,200
0.05% 91
2019
Q3
$109K Hold
6,200
0.05% 90
2019
Q2
$132K Hold
6,200
0.07% 79
2019
Q1
$148K Sell
6,200
-1,545
-20% -$35.2K 0.08% 80
2018
Q4
$152K Buy
+7,745
New +$138K 0.09% 76

Other funds holding EXEL

Blume Capital Management's EXEL Position: Q2 2024 in Review

Blume Capital Management sold out of Exelixis (EXEL) in Q2 2024, closing a stake of 400 shares — an estimated $9.49K sold.

Blume Capital Management first reported a position in EXEL in Q4 2018 and held it in 22 quarters. The position peaked at $152K in Q4 2018. 413 funds tracked by Wall St. Rank hold EXEL as of Q2 2024.

  • Blume Capital Management reported no remaining Exelixis position as of Q2 2024 after selling out during the quarter.
  • Blume Capital Management sold 400 Exelixis shares in Q2 2024, an estimated $9.49K.
  • Blume Capital Management first reported a position in Exelixis in Q4 2018 and held it in 22 quarters.
  • Blume Capital Management's Exelixis position peaked at $152K in Q4 2018.
  • 413 funds tracked by Wall St. Rank held Exelixis as of Q2 2024.

Based on Blume Capital Management's 13F filing for Q2 2024, filed 5 Aug 2024.